Remove 2007 Remove Access Remove Treatment
article thumbnail

Dr. Andrew Weil on Cannabis and Integrative Medicine

Project CBD

He is the author of several bestselling books, including Spontaneous Healing (1995), Eating Well for Optimum Health (2000), and Healthy Aging (2007). And then cannabis has unique effects for a wide range of conditions, everything from the treatment of pain, treatment of asthma, treatment of immune conditions.

Medicine 308
article thumbnail

Pot in the can: Why can’t inmates get medical marijuana?

The Cannigma

A United Kingdom police chief proposed a novel idea this January: Allow drug-dependent inmates access to free cannabis to help them overcome opioid addiction. This creates a situation where state detention facilities — even where cannabis is legal — do not allow inmates access to medical cannabis because it violates federal law.

Marijuana 145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Canada: J&J’s Janssen Denied Data Protection Rights For Ketamine Analog Spravato In Canada, Court Rules ‘Not An Innovative Drug’

Cannabis Law Report

Ketamine and its treatment protocols are effectively laying the groundwork for the development of an infrastructure that could ultimately result in the introduction of psychedelics in a clinical setting. Prior to 2007, the U.S. Spravato is the first “psychedelic-like” medicine approved for a mental health indication in both the U.S.

Data 98
article thumbnail

CDC study finds teen pot treatment admissions plummeted

SpeedWeed

The CDC report found “a precipitous national decline in adolescent treatment admissions, particularly in states legalizing recreational marijuana use,” states study author Jeremy Mennis, Ph.D. “7 As legalization throttled up from 2008 to 2017, teens going to the hospital for pot treatment plummeted from about 60 cases per 100,000 to 31.

article thumbnail

Press Release: COMPASS Pathways joins forces with King’s College London and South London and Maudsley NHS Foundation Trust to accelerate psychedelic research and develop new models of mental health care in the UK

Cannabis Law Report

Professor Allan Young, Head of Academic Psychiatry at King’s IoPPN, said, “We have been in partnership with SLaM at the Maudsley Biomedical Research Centre since 2007, and with COMPASS on COMP360 psilocybin therapy research since 2018. London, UK – 5 July 2021. George Goldsmith, CEO and Co?founder,

article thumbnail

Former member of the National Advisory Council on Drug Abuse (NACDA) and National Institute on Drug Abuse (NIDA) Joins Ehave, Inc; Ehave Appoints Psychopharmacologist, Board-Certified Psychiatrist, And Licensed Physician, Bankole Johnson To Its Medical Advisory Board

Cannabis Law Report

Johnson’s primary area of research expertise is the psychopharmacology of medications for treating addictions, and he is well known in the field for his discovery that topiramate, a gamma-aminobutyric acid (GABA) facilitator and glutamate antagonist, an effective treatment for alcoholism. ” About Ehave, Inc. Ehave, Inc.

article thumbnail

Europe’s Leading Psychedelic Conference Returns to Amsterdam In September

Cannabis Law Report

Since 2007 our focus has been on high-quality science”, said Breeksema. And how do we make sure treatments are safe, accessible, and inclusive? But we are talking about vulnerable people receiving very powerful and potentially destabilising experiences. We need to talk about challenges and risks transparently.